Investors who have long believed in Ambrx Biopharma Inc. are now enjoying substantial returns as Johnson & Johnson's acquisition offer values the biotech stock...
South Korea's equity market is experiencing increased turbulence as investors turn to single stock futures to place bearish bets, an unintended consequence of last...